文献速递心血管MR

心脏MRI舒张功能指标对不良心血管结局的预后价值

Prognostic Value of Cardiac MRI-derived Diastolic Function for Adverse Cardiovascular Outcomes: Insights from UK Biobank.
PubMed 文献 · Radiology · 2026-01-01

结果显示峰值e'SR、E/A、LAVmax与心衰及心律失常独立相关,E/e'SR在LVEF和GLS基础上提供增量预后价值。

要点

  • 峰值e'SR是心衰最强的独立预测指标,阅片时应重视舒张早期纵向应变率
  • E/e'SR可在LVEF和GLS之外增加预后信息,报告可补充该比值
  • 心脏MRI舒张功能指标与全因死亡无独立关联,解读预后时需结合其他因素

核心结论

  • 心脏MRI舒张功能指标可独立预测心衰和心律失常,E/e'SR在LVEF与GLS基础上具有增量预后价值,但与全因死亡无独立关联。

研究设计与样本

  • 使用单变量和多变量Cox模型评估E/A、峰值e'SR、E/e'SR及LAVmax对心衰、心律失常和全因死亡的预后影响。
  • 多变量模型校正年龄、性别、吸烟、BMI、高血压、糖尿病、高脂血症及LVEF、GLS、LVEDVi、LVMi等已知影像指标。

关键影像表现/征象

  • E/A及峰值e'SR亦与心律失常独立相关,提示舒张功能障碍与心律失常发生存在关联。

诊断标准与关键数值

  • 峰值e'SR在所有舒张功能指标中心衰预测关联最强,E/e'SR在LVEF和GLS基础上提供增量预后信息。
  • 全因死亡:校正后各舒张功能指标均无统计学显著关联。

临床应用与阅片要点

  • 心脏MRI报告中应常规测量并记录峰值e'SR、E/e'SR及LAVmax,峰值e'SR降低对心衰预测价值最高。
  • 在LVEF正常或GLS未见明显异常时,E/e'SR升高仍提示舒张功能障碍及不良预后,不宜漏报。
  • 使用舒张功能指标判断预后时需同时校正临床心血管危险因素及左室重构指标。

局限性

  • 本研究为英国生物银行数据的二次分析,存在选择偏倚和残余混杂可能。
  • 未明确报告心脏MRI具体序列参数及舒张功能指标测量的标准化方法。
  • 中位随访6年,对全因死亡等长期结局的评估可能不充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Although diastolic function markers can help predict adverse outcomes in cardiac disease, the prognostic value of cardiac MRI-derived metrics at a population level remains unclear. Purpose To assess the independent and incremental prognostic value of cardiac MRI-derived diastolic function metrics for adverse cardiovascular outcomes in the UK Biobank. Materials and Methods This secondary analysis of the UK Biobank used data from participants enrolled between March 2006 and August 2010. Univariable and multivariable Cox models were used to evaluate the prognostic influence of each diastolic function marker (peak early to peak late mitral filling rate ratio [E/A], peak early diastolic longitudinal strain rate [e'SR], peak early mitral filling rate to peak e'SR ratio [E/e'SR], and maximum left atrial volume [LAVmax]) on adverse outcomes, including heart failure (HF), arrhythmia, and all-cause death. Multivariable models were adjusted for clinical cardiovascular risk factors (age, sex, smoking, body mass index, hypertension, diabetes, and hyperlipidemia) and known prognostic imaging markers (left ventricular [LV] ejection fraction [LVEF], global longitudinal strain [GLS], LV end-diastolic volume index, and LV mass index). Results The cohort included 59 416 individuals (mean age, 65.4 years ± 7.7 [SD]; 30 887 women) with a median follow-up of 6 years. Peak e'SR, E/A, and LAVmax were independently associated with incident HF and arrhythmia, with peak e'SR showing the strongest association (hazard ratio [HR], 0.55 [95% CI: 0.50, 0.61] for HF, 1.37 [95% CI: 1.26, 1.49] for E/e'SR, and 1.28 [95% CI: 1.17, 1.40] for LAVmax; all P < .001). E/e'SR provided incremental value beyond LVEF and GLS. There was no evidence that diastolic markers were associated with incident all-cause death in fully adjusted models. Conclusion Cardiac MRI-derived diastolic function metrics independently predicted HF and arrhythmia in the UK Biobank with incremental value beyond established imaging markers. © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Ishida in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Mahmood, Chadalavada, Hesse, et al. Prognostic Value of Cardiac MRI-derived Diastolic Function for Adverse Cardiovascular Outcomes: Insights from UK Biobank. Radiology. 2026. PMID: 42808898. doi:10.1148/radiol.253712

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。